Target intelligence / Profile preview

RNA, U6 small nuclear 301, pseudogene (RNU6-301P)

Target
RNU6-301P
Molecular classification
Other (pseudogene, noncoding RNA; not a protein-coding gene, receptor, enzyme, transporter, etc.)[1][5]
01

Overview

RNA, U6 small nuclear 301, pseudogene (RNU6-301P) is a human **pseudogene** locus annotated by the HUGO Gene Nomenclature Committee (HGNC)[1][5]. It is related by sequence to the U6 small nuclear RNA genes, which encode a component of the spliceosome involved in intron removal from pre-mRNA. As a pseudogene, RNU6-301P is not predicted to produce a functional U6 small nuclear RNA or protein. While some pseudogenes transcribe noncoding RNAs that can regulate genes or act as molecular decoys in certain contexts, there is no evidence supporting a functional, regulatory, or disease role specific to RNU6-301P. It is not considered a therapeutic target, receptor, enzyme, transporter, or biomarker. Key points: - RNU6-301P is a non-protein-coding pseudogene, not a functional receptor, enzyme, or other classic drug target[1][5]. - Its sequence is related to U6 snRNA genes, which are important for mRNA splicing, but it is not expected to participate in this process[5]. - While pseudogenes in general may have regulatory RNA roles, there is no specific information about such a function for RNU6-301P[2][4]. - No drugs, biomarkers, or disease roles are associated with RNU6-301P itself.

Other names
RNU6-301P
02

Biological functions

Potential regulation of gene expression through RNA-based mechanisms (e.g., may be transcribed, may participate in regulatory noncoding RNA networks in principle, but no specific activity assigned for this locus)[2][4]
03

Disease associations

Other (no evidence for a direct role in disease; pseudogenes can act as regulatory RNAs in cancer and other diseases, but no specific disease association for RNU6-301P)[2][4][5]

Beyond the preview

Go deeper on RNA, U6 small nuclear 301, pseudogene (RNU6-301P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 301, pseudogene (RNU6-301P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call